I would like to see how Momenta would issue A/W rights to a patent that it already assigned exclusive rights to someone else. I'm sure Sandoz would have something to say about any settlement that would only benefit Momenta.
The launch delay does benefit Sandoz substantially. Also, MNTA is giving up more in potential damages (both on the contract reset and non sales related issues).
I agree that NVS is a party here, but the range of terms that DD suggests is not that one-sided. In some cases (2015 and 10%) they could well be better for NVS than MNTA compared to expected value, while others (2013 and 20%) could be the reverse.
For a poll question, it seams like DD has a reasonable pallet of choices.